Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
Congratulations to the 2021 recipients of Conquer Cancer/ASCO awards for young investigators who are working on innovative research projects aimed at advancing cancer care and treatment.
A new study finds that cervical cancer screening tests are frequently overused among commercially insured women with average risk of developing cancer.
As a skin cancer specialist, Dr. Larisa Geskin has devoted her career to treating patients and promoting awareness about cancer prevention and the importance of daily sunscreen usage.
A new study by HICCC members shows that the presence of a rare and previously unknown type of immune cell in kidney tumors can predict which patients are likely to have cancer recur after surgery.
Congratulations to Drs. Christine Iok In Chio and Xuebing Wu, recipients of the 2021 Pershing Square Sohn Prize for their out-of-the box approaches to cancer research.
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
Silver nanoclusters—which could be applied to the treatment of cancer in the future—block an early step of DNA replication, a new study by Columbia cancer researchers has found.
A study, led by Benjamin Izar, MD, is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, and provides leads to why severe cases of COVID-19 experience long-term complications.
The biological reasons for racial disparities in breast cancer still aren’t fully understood, but a new study highlights a prognostic biomarker called Kaiso that may provide some insight.